Current Liabilities Changement Date
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amarin USD 266.69M 4.24M 2023-09
Amgen USD 18.39B 1.44B 2023-12
Arrowhead Research USD 63.72M 41.73M 2023-12
AstraZeneca USD 28.59B 2.21B 2023-09
Biogen USD 3.43B 1.59B 2023-12
Bluebird Bio USD 158.96M 23.94M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Enanta Pharmaceuticals USD 62.79M 5.4M 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
Galectin Therapeutics USD 10.52M 569K 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
Incyte USD 1.24B 115.7M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Moderna USD 3.02B 1.37B 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
PTC Therapeutics USD 603.1M 110.98M 2023-12
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Intercept Pharmaceuticals Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.